Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

University of British Columbia

$100,000.00

ERG-induced transformation of prostatic epithelial cells

FY 2008-09

Summary
Specific genetic changes are linked to certain cancers. This knowledge has lead to development of targeted therapies that significantly improve patient survival. In 2005, a landmark report identified a recurring genetic rearrangement called a 'translocation' that connected the testosterone responsive sequence of the gene TMPRSS2 onto two Ets family genes associated with sarcomas, ERG and ETV1. These translocations are associated with poor prognosis for prostate cancer patients and we have shown that ERG is sufficient to transform non-tumorigenic prostate cells. We hypothesize that ERG causes them to grow faster and makes them more capable of metastasizing. We hypothesize that ERG causes them to grow faster and makes them more capable of metastasizing. By determining the parts of ERG that are expressed in tumors, how different parts affect tumor formation, and alter hormone dependence and cell communication, these studies will teach us how ERG causes prostate cancer and hopefully how to treat patients with these translocations.
Program
Operating Grant
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
183802
Name
Cox Michael E
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Molecular & Cellular Biology of Cancer
Projecttitle
ERG-induced transformation of prostatic epithelial cells
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Animal Models; Epithelial-To-Mesenchymal Transition; Ets Transcription Factors; Metastasis; Prostate Cancer; Transformation
Abstract
Specific genetic changes are linked to certain cancers. This knowledge has lead to development of targeted therapies that significantly improve patient survival. In 2005, a landmark report identified a recurring genetic rearrangement called a 'translocation' that connected the testosterone responsive sequence of the gene TMPRSS2 onto two Ets family genes associated with sarcomas, ERG and ETV1. These translocations are associated with poor prognosis for prostate cancer patients and we have shown that ERG is sufficient to transform non-tumorigenic prostate cells. We hypothesize that ERG causes them to grow faster and makes them more capable of metastasizing. We hypothesize that ERG causes them to grow faster and makes them more capable of metastasizing. By determining the parts of ERG that are expressed in tumors, how different parts affect tumor formation, and alter hormone dependence and cell communication, these studies will teach us how ERG causes prostate cancer and hopefully how to treat patients with these translocations.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cox, Michael E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~